Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...
A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...
Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...
Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...
For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...
Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
4don MSN
As Trump administration cuts HIV research funding, Atlanta doctors warn of impact on clinics
As HIV diagnoses continue increasing in metro Atlanta, the number of dollars for research and treatment is going down.
Amazon S3 on MSN
A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
A twice-yearly injection described as the most promising HIV prevention tool in decades is poised to reach millions more people, with new generic versions priced at about $40 per patient per year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback